Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C
Silvia Barbaliscia(University of Rome Tor Vergata), Maurizio Zazzi(University of Siena), Luca Carioti(University of Rome Tor Vergata), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Adriano Pellicelli(Carlo Forlanini Hospital), Anna Licata(University of Palermo), Elisabetta Teti(University of Rome Tor Vergata), Roberto Gulminetti(University of Pavia), C. Paternoster, Laura Ambra Nicolini(Ospedale Policlinico San Martino), Loredana Sarmati(University of Rome Tor Vergata), Bianca Bruzzone(Ospedale Policlinico San Martino), Stefania Paolucci(Policlinico San Matteo Fondazione), Simona Landonio(ASST Fatebenefratelli Sacco), Claudio Maria Mastroianni(Sapienza University of Rome), M. Aragri(University of Rome Tor Vergata), C. Pasquazzi(Azienda Ospedaliera Sant'Andrea), Sergio Babudieri(University of Sassari), Francesco Di Lorenzo(Fondazione Santa Lucia), Fausto Baldanti(University of Pavia), Ada Bertoli(IRCCS Policlinico San Donato), Laura Monno(University of Bari Aldo Moro), V. Di Marco(University of Palermo), Hamid Hasson(Vita-Salute San Raffaele University), Lavinia Fabeni, Vincenzo Sangiovanni(Ospedale Sant'Anna), Gloria Taliani(Sapienza University of Rome), Teresa Pollicino(University of Messina), Mariano Quartini, Nicola Coppola(University of Campania "Luigi Vanvitelli"), Velia Chiara Di Maio(University of Rome Tor Vergata), A Pieri(Azienda USL di Pescara), Leonardo Baiocchi(Policlinico Tor Vergata), Pietro Andreoné, Giustino Parruti(Azienda USL di Pescara), Valeria Micheli(ASST Fatebenefratelli Sacco), Stefano Novati(Policlinico San Matteo Fondazione), Raffaele Cozzolongo, Katia Yu La Rosa(University of Rome Tor Vergata), Carmine Minichini(University of Campania "Luigi Vanvitelli"), N. Iapadre(San Salvatore Hospital), Stefano Marenco(National Institutes of Health), Barbara Rossetti, Martina Milana(University of Rome Tor Vergata), Enzo Boeri(National Cancer Institute), A.P. Callegaro(Ospedale Papa Giovanni XXIII), Filomena Morisco, Valeria Pace Palitti(Azienda USL di Pescara), Miriam Lichtner(Sapienza University of Rome)
Cited by 0
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
|American Journal of Transplantation|2016|631
Comprehensive approach for correction of motion and distortion in diffusion‐weighted MRI
|Magnetic Resonance in Medicine|2003|547